Analystreport

CytomX Therapeutics Inc (NASDAQ: CTMX) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $16.00 price target on the stock.

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com